Cargando…
A new horizon of moyamoya disease and associated health risks explored through RNF213
The cerebrovascular disorder moyamoya disease (MMD) was first described in 1957 in Japan, and is typically considered to be an Asian-specific disease. However, it is globally recognized as one of the major causes of childhood stroke. Although several monogenic diseases are known to be complicated by...
Autores principales: | Koizumi, Akio, Kobayashi, Hatasu, Hitomi, Toshiaki, Harada, Kouji H., Habu, Toshiyuki, Youssefian, Shohab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771639/ https://www.ncbi.nlm.nih.gov/pubmed/26662949 http://dx.doi.org/10.1007/s12199-015-0498-7 |
Ejemplares similares
-
RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients
por: Kobayashi, Hatasu, et al.
Publicado: (2016) -
Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice
por: Kobayashi, Hatasu, et al.
Publicado: (2018) -
Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo
por: Kobayashi, Hatasu, et al.
Publicado: (2015) -
Dysregulation of RNF213 promotes cerebral hypoperfusion
por: Morimoto, Takaaki, et al.
Publicado: (2018) -
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
por: Liu, Wanyang, et al.
Publicado: (2011)